Cold War tensions and the polio vaccine Sabin vaccine from the Soviet side. However other Soviet virologists argued that the Salk vaccine could be considered safe, since the Americans tested it on their own people. They considered that the Sabin vaccine must be potentially dangerous because the Americans did not wish to test it on their own society. The documented achievement of the Sabin-Chumakov collaboration eventually trumped the ideological differences of the Cold War. Their oral live-virus vaccine became federally licensed in 1962, and used for over three decades to help eliminate polio globally, replacing the Salk vaccine. Using these vaccines, the threat of polio remains only
Influenza vaccine sera (chiefly against what we now call "Hemophilus influenzae"—a name derived from the fact that it was originally considered the etiological agent—and several types of pneumococci). Only one therapeutic measure, transfusing blood from recovered patients to new victims, showed any hint of success." In 1931, viral growth in embryonated hens' eggs was reported by Ernest William Goodpasture and colleagues at Vanderbilt University. The work was extended to growth of influenza virus by several workers, including Thomas Francis, Jonas Salk, Wilson Smith and Macfarlane Burnet, leading to the first experimental influenza vaccines. In the 1940s, the US military developed the first